3 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
Perspective Individual’s burden of disease Physicians Perspective Efficient, cost-effective treatments Societal Perspective Pharma industry obligation
8-K
EX-99.2
KPRX
Kiora Pharmaceuticals Inc
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
Retinal Diseases Patient Perspective Individual’s burden of disease Physicians Perspective Efficient, cost-effective treatments Societal Perspective
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Regulation FD Disclosure
7:02am
Physicians Perspec/ve Efficient, cost-effec8ve treatments Societal Perspective Pharma industry obligation to help
4 Why Retinal Diseases? “…the last light
- Prev
- 1
- Next